Hypoglycemia is a pathological condition characterized by a low plasma glucose concentration associated with typical autonomic and/or neuroglycopenic symptoms, and resolution of these symptoms with carbohydrate consumption. Hypoglycemia is quite common in clinical practice, particularly in insulin-treated patients with diabetes and in other inherited or acquired conditions involving the regulation of glucose metabolism. Beyond symptoms that might strongly affect the quality of life, hypoglycemia can lead to short- and long-term detrimental consequences for health. Hypoglycemia can be prevented by appropriate changes in dietary habits or by relevant modifications of the drug treatment. Several dietary approaches based on the intake of various carbohydrate foods have been tested for hypoglycemia prevention; among them uncooked cornstarch (UCS) has demonstrated a great efficacy. In this narrative review, we have summarized the current evidence on the UCS usefulness in some conditions characterized by high hypoglycemic risk, focusing on some inherited diseases - glycogen storage diseases and other rare disorders - and acquired conditions such as type 1 diabetes, postprandial hypoglycemia consequent to esophageal-gastric or bariatric surgery, and insulin autoimmune syndrome. We also considered the possible role of UCS during endurance exercise performance. Lastly, we have discussed the dose requirement, the side effects, the limitations of UCS use, and the plausible mechanisms by which UCS could prevent hypoglycemia.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10408398.2020.1864617DOI Listing

Publication Analysis

Top Keywords

uncooked cornstarch
8
acquired conditions
8
hypoglycemia
7
ucs
5
cornstarch prevention
4
prevention hypoglycemic
4
hypoglycemic events
4
events hypoglycemia
4
hypoglycemia pathological
4
pathological condition
4

Similar Publications

[Genetic and clinical characteristics of 26 cases with glycogen storage disease type Ⅲ].

Zhonghua Gan Zang Bing Za Zhi

November 2024

The Center for Pediatric Liver Diseases, Children's Hospital of Fudan University, Shanghai201102, China.

Article Synopsis
  • The study analyzed the genetic and clinical profiles of 26 patients with glycogen storage disease type III (GSD III), focusing on the effects of different genetic mutations in the AGL gene.
  • It found that the most common symptoms included elevated liver enzymes, hepatomegaly, and fasting hypoglycemia, and that liver biopsies revealed significant fibrosis in 83.3% of cases.
  • After treatment with uncooked cornstarch for over a year, patients showed improvements in growth, liver size, and metabolic markers, although a subset of cases still experienced clinical issues.
View Article and Find Full Text PDF

The influence of pulse cell wall structure and cellular protein matrix on the in vitro digestion kinetics of starch: A dual encapsulation mechanism.

Food Res Int

December 2024

School of Food Science and Engineering, Guangdong Province Key Laboratory for Green Processing of Natural Products and Product Safety, South China University of Technology, Guangzhou 510640, China; Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health (111 Center), Guangzhou, China. Electronic address:

The intrinsic characteristics and extrinsic processing of whole-pulse food modulate the starch digestion rate and extent. This study investigated the dual encapsulation mechanism of cell wall structure and protein matrix on the in vitro digestion properties of intracellular starch, using an isolated whole-pulse food model of intact pea cotyledon cells subjected to alkaline buffer and enzymatic treatments. Results showed that intact cells with the maximum protein matrix content (18.

View Article and Find Full Text PDF

Rationale: Glycogen storage disease type 0a (GSD0a) is a rare autosomal recessive disorder caused by glycogen synthase deficiency. Short stature is a characteristic feature in 29% of GSD0a patients, but isolated short stature as the only presenting symptom is exceedingly rare, with only 2 cases reported worldwide.

Patient Concerns: A 4-year-old girl presented with persistent growth retardation despite previous treatment for renal tubular acidosis.

View Article and Find Full Text PDF

Potential use of other starch sources in the treatment of glycogen storage disease type Ia - an in vitro study.

Orphanet J Rare Dis

July 2024

Postgraduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Article Synopsis
  • * Sweet manioc starch was tested and shows promise as an alternative treatment, with moisture and sugar content analyzed in various samples.
  • * Future clinical trials are needed to evaluate the effectiveness of sweet manioc starch compared to uncooked cornstarch in treating GSD-Ia.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!